investing.comAUG 312 min read$CVS

Top healthcare services stock to watch, according to Jefferies

Jefferies highlights CVS Health as a top healthcare services pick, citing strong Q2 earnings, a $120 price target, and factors like Aetna's recovery and buyback potential. CVS reported Q2 adjusted EPS of $2.58 on revenue of $106.1B, raising its full-year outlook. Moody's upgraded CVS's outlook to positive, noting progress in its health insurance business.

Original reporting

investing.com

Published Aug 31, 2026, 6:43 PM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Aug 31, 2026, 7:06 PM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

alphai market briefEarnings

Primary signal

$CVS

Bullish

high confidence

Mentioned

$CVS · $HCSG

Relevance

7/10

alphai data visualization · based on investing.com

Decision brief

The 30-second read

$CVSBullishMed

Why it matters

Analyst upgrade with a sizable price target could drive buying interest and short covering.

Market read

The upgrade may trigger a short‑term price rally in CVS and influence sentiment toward the broader healthcare services sector.

What to watch

Potential headwinds from 340B pressure and Caremark membership declines.

Relevance 7/10Novelty 6/10Timing: post‑earnings today

Background

Jefferies highlights CVS Health as a top pick after its Q2 2026 earnings beat and guidance raise.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CVSBullishHigh confidence

Context

Jefferies upgraded CVS Health to Buy with a $120 price target after Q2 2026 earnings beat and raised guidance.

Expected impact

Potential short-term rally toward $120 target.

Evidence & confidence

Upgrade is based on strong earnings, cash flow and buyback expectations.

Market effects

Sector

Positive outlook may lift other large‑cap healthcare services stocks.

Regional

U.S. healthcare sector could see modest gains.

Global

Limited to U.S. markets; no direct global effect.

Counterpoint

What could challenge this read

Buyback resumption is uncertain; valuation may already price in upside.

Key entities

company
CVS Health
U.S. healthcare services and pharmacy retailer.
analyst_firm
Jefferies
Investment bank providing the upgrade and target.

Read at source ← All news

SEP 1

$CVSHigh

Why CVS Stock Rallied Tuesday Morning

CVS Health (CVS) shares rose 3.7% Tuesday morning, driven by Jefferies analyst Brian Tanquilut's bullish commentary. He affirmed a buy rating with a $120 price target, citing management's EPS outlook of at least $8.44 for 2027, share buybacks, and Aetna's recovery. CVS has beaten earnings expectations for four straight quarters and raised its full-year guidance to $8.00 EPS.

yahoo.com2 min

AUG 29

$CVSHighAI 8/10

CVS Raised 2026 Guidance. Its First 2027 Number Is What Spooked the Market.

CVS Health reported Q2 adjusted EPS of $2.58, beating estimates by 73 cents, with revenue up 7.3% YoY to $106.1B. The company raised 2026 adjusted EPS guidance to $7.90-$8.10 but provided an in-line 2027 outlook, causing a 6% stock drop. Analysts remain bullish, with a mean target of $116, 25% above the current price.

tikr.com3 min

AUG 28

$ELVHighAI 8/10

Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers

CVS Health (CVS) reported $106.1B revenue, up 7.3% YoY, beating estimates. UnitedHealth (UNH) reported $112B revenue, flat YoY, also beating estimates. Progyny (PGNY) reported $350.5M revenue, up 5.3% YoY, missing guidance. Molina Healthcare (MOH) reported $10.87B revenue, down 4.8% YoY, missing guidance. All stocks have declined since earnings.

yahoo.com3 min

AUG 28

$CVSMed

Froedtert Hospital sues CVS Health alleging fraud and $18M in losses

Froedtert Hospital sued CVS Health, alleging the company manipulated a federal drug discount program and diverted $18M. CVS denies the claims, calling them erroneous. Other hospitals have filed similar lawsuits. CVS reported $402B in revenue last year.

jsonline.com2 min

AUG 24

$UNHHighAI 8/10

Health Insurer Stocks Are Soaring As Companies Get A Handle On Costs

UnitedHealth Group reported $5B in Q2 net income, with a declining medical care ratio. Shares of UnitedHealth, CVS Health, Centene, and Humana have risen significantly. Centene and Humana reported strong earnings, while Humana plans to exit some markets in 2027. Oscar Health entered new markets and saw its stock triple in six months.

forbes.com3 min

AUG 22